73 related articles for article (PubMed ID: 9949667)
1. Epidemiology and prognosis of Pseudomonas aeruginosa bacteremia in a tertiary care center.
Sifuentes-Osornio J; Gonzalez R; Ponce-de-Leon A; Guerrero ML
Rev Invest Clin; 1998; 50(5):383-8. PubMed ID: 9949667
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes.
Vidal F; Mensa J; Almela M; Martínez JA; Marco F; Casals C; Gatell JM; Soriano E; Jimenez de Anta MT
Arch Intern Med; 1996 Oct; 156(18):2121-6. PubMed ID: 8862105
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa bacteraemia. Is pancreatobiliary disease a risk factor?
Chen SC; Lawrence RH; Byth K; Sorrell TC
Med J Aust; 1993 Nov; 159(9):592-7. PubMed ID: 8232033
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.
Kang CI; Kim SH; Kim HB; Park SW; Choe YJ; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2003 Sep; 37(6):745-51. PubMed ID: 12955633
[TBL] [Abstract][Full Text] [Related]
5. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of Pseudomonas aeruginosa bacteremia].
Kumasaka K; Hosokawa N; Yanai M; Yagoshi M; Simoguchi K; Kawano K
Rinsho Byori; 1999 Nov; 47(11):1064-9. PubMed ID: 10590685
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Clin Microbiol Infect; 2005 May; 11(5):415-8. PubMed ID: 15819873
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia.
Cheong HS; Kang CI; Wi YM; Kim ES; Lee JS; Ko KS; Chung DR; Lee NY; Song JH; Peck KR
Am J Med; 2008 Aug; 121(8):709-14. PubMed ID: 18691485
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients.
Johnson LE; D'Agata EM; Paterson DL; Clarke L; Qureshi ZA; Potoski BA; Peleg AY
Transpl Infect Dis; 2009 Jun; 11(3):227-34. PubMed ID: 19302282
[TBL] [Abstract][Full Text] [Related]
10. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection.
Lodise TP; Patel N; Kwa A; Graves J; Furuno JP; Graffunder E; Lomaestro B; McGregor JC
Antimicrob Agents Chemother; 2007 Oct; 51(10):3510-5. PubMed ID: 17646415
[TBL] [Abstract][Full Text] [Related]
11. [Trends for bacteremia and risk factors for death in a tertiary hospital in Mexico City. 1981-1992].
Sifuentes-Osornio J; Guerrero-Almeida MC; Ponce de León-Garduño LA; Guerrero-Almeida ML
Gac Med Mex; 2001; 137(3):191-202. PubMed ID: 11432088
[TBL] [Abstract][Full Text] [Related]
12. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.
Garnacho-Montero J; Sa-Borges M; Sole-Violan J; Barcenilla F; Escoresca-Ortega A; Ochoa M; Cayuela A; Rello J
Crit Care Med; 2007 Aug; 35(8):1888-95. PubMed ID: 17581492
[TBL] [Abstract][Full Text] [Related]
13. Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected?
Schechner V; Nobre V; Kaye KS; Leshno M; Giladi M; Rohner P; Harbarth S; Anderson DJ; Karchmer AW; Schwaber MJ; Carmeli Y
Clin Infect Dis; 2009 Mar; 48(5):580-6. PubMed ID: 19191643
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors of bacteremia: prospective study].
Pazos Añón R; Fernández Rodríguez R; Paz Vidal I; Tinajas A; Cantón I; Abel V; González R; Martínez R; Gayoso P; Fernández Alvarez O
An Med Interna; 2001 Aug; 18(8):415-20. PubMed ID: 11589079
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
Tsai MS; Kuo CY; Wang MC; Wu HC; Chien CC; Liu JW
J Microbiol Immunol Infect; 2006 Apr; 39(2):150-4. PubMed ID: 16604248
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for Pseudomonas aeruginosa bacteremia in Thai patients.
Siripassorn K; Santiprasitkul S; Udompanthurak S; Thamlikitkul V
J Med Assoc Thai; 2002 Oct; 85(10):1095-9. PubMed ID: 12501901
[TBL] [Abstract][Full Text] [Related]
17. Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and treatment.
Marcus N; Ashkenazi S; Samra Z; Cohen A; Livni G
Infection; 2008 Oct; 36(5):421-6. PubMed ID: 18795227
[TBL] [Abstract][Full Text] [Related]
18. [Risk factors and prognosis of nosocomial pneumonia due to gram-negative bacteria in a general hospital].
Martínez B; Gómez J; Gómez Vargas J; Gómez JR; Baños V; Sánchez ME; Canteras M; Valdés M
Rev Esp Quimioter; 2000 Jun; 13(2):187-92. PubMed ID: 10918093
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
[TBL] [Abstract][Full Text] [Related]
20. [Pseudomonas aeruginosa bacteremia as a complication after endoscopic retrograde cholangiopancreatography].
Rodríguez Guardado A; Maradona JA; Cartón JA; Hooker N; Alonso JL; Asensi V; Arribas JM
Enferm Infecc Microbiol Clin; 1997 Dec; 15(10):540-3. PubMed ID: 9522518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
